mefenamic acid Side Effects
Also known as: Ponstel
Analysis of 2,104 adverse event reports submitted to the FDA from 2004 to 2025.
Total Reports
2,104
Death-Related
81
3.8% of reports
Hospitalizations
707
33.6% of reports
Top Indication
Product Used For Unknown Indication
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 81 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| CONDITION AGGRAVATED | 8 |
| DEATH | 8 |
| DECREASED APPETITE | 8 |
| DIZZINESS | 8 |
| ARTHRALGIA | 7 |
| DIARRHOEA | 7 |
| OVERDOSE | 7 |
| SEPTIC SHOCK | 7 |
| ABDOMINAL PAIN UPPER | 6 |
| ADJUSTMENT DISORDER WITH DEPRESSED MOOD | 6 |
| ALOPECIA | 6 |
| ANXIETY | 6 |
| BREAST CANCER STAGE III | 6 |
| BURSITIS | 6 |
| COLITIS ULCERATIVE | 6 |
| CONFUSIONAL STATE | 6 |
| CONTUSION | 6 |
| CROHN^S DISEASE | 6 |
| DELIRIUM | 6 |
| DISLOCATION OF VERTEBRA | 6 |
Reactions in Hospitalization Reports
Top reactions in 707 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| VOMITING | 80 |
| NAUSEA | 60 |
| DIZZINESS | 51 |
| HEADACHE | 51 |
| DIARRHOEA | 47 |
| DRUG INTERACTION | 46 |
| DRUG INEFFECTIVE | 42 |
| PYREXIA | 40 |
| RENAL FAILURE ACUTE | 37 |
| DYSPNOEA | 35 |
| OFF LABEL USE | 35 |
| TOXICITY TO VARIOUS AGENTS | 34 |
| MALAISE | 33 |
| ACUTE KIDNEY INJURY | 30 |
| ABDOMINAL DISCOMFORT | 29 |
| ABDOMINAL PAIN | 29 |
| CHILLS | 29 |
| HYPOTENSION | 29 |
| PAIN | 28 |
| ABDOMINAL PAIN UPPER | 27 |
Nearby — Related Medications
What the FAERS Data Reveals About mefenamic acid Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 2,104 voluntary reports linked to mefenamic acid and its brand equivalents (Ponstel), spanning 2004 through 2025. Of those, 81 (3.8%) listed death as an outcome and 707 (33.6%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 78% were female and 22% male; age distribution skews toward 18-44, with 668 reports in that bracket. The single most reported reaction is drug ineffective with 352 submissions, followed by nausea and fatigue.
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice — speak with a licensed clinician about any side-effect concerns.
Read our methodology — how this data is sourced, computed, and verified.